At least 12 therapies for amyotrophic lateral sclerosis (ALS) are in or about to start clinical testing. The therapies range from neuroprotectants and neurotrophic factors to muscle activators and neural cell replacements. Source: BCIQ: BioCentury Online Intelligence

Company

Product

Description

Status

Eisai Co. Ltd. (Tokyo:4523; Osaka:4523)

Mecobalamin (E0302)

Mecobalamin (vitamin B12 coenzyme) formulation

Ph III